The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease

• Conditions: COVID-19; Perception, Self; Facilities and Services Utilization
• Interventions: Other: Interview

• Registration Number: NCT04387279
• Lead Sponsor: Keimyung University Dongsan Medical Center

Brief Summary

The rapid spread of COVID-19 is expected to have a significant impact on medicine as well as all sectors worldwide. In particular, inflammatory bowel disease (IBD) is a chronic immune disease in which remission and activation are repeated and must be treated consistently throughout life. In addition, patients with IBD may be vulnerable to various infectious diseases due to the immuno-compromised state due to the use of immuno-suppressants or biological agents. During a pandemic, patients with IBD may postpone hospital visits due to concerns about infection with COVID-19, and if they cannot continue drug treatment, there is a concern about the flare up IBD disease activity. Therefore, in this study, we would like to investigate the current status of hospital utilization of IBD patients in Daegu, the epidemic area of COVID-19, and to investigate the effect of patient perception of COVID-19 on hospital ultilization.

Detailed Description

Background: In the epidemic area of COVID-19, emergency treatment of chronic diseases other than COVID-19 can be limited. Therefore, it is important to reduce the risk of exposure to COVID-19 in patients with chronic immune diseases such as IBD, but it is most important to manage well so that the underlying diseases are not exacerbated at times when emergency medical treatment may be difficult. However, there is a lack of evidence on the management policy of chronic immune diseases in the current epidemic, and only expert opinions are being presented.

Aim: To investigate the current status of hospital utilization of IBD patients in Daegu, the epidemic area of COVID-19, and to investigate the effect of patient perception of COVID-19 on hospital utilization.

Material and method: This study is a multicenter, prospective, cross-sectional survey which will be consulted in Keimyung University Dongsan Medical Center and Yeungnam University Hospital. Patients with IBD aged above 18 will enrolled and surveyed about their perception about COVID-19 and status of hospital utilization during pandemic period. Patients' demographics and disease-related variables will be evaluated to identify clinical significances.

Study Timeline

• Study Start: 2020-04-24
• Status Verified: 2020-05
• Study First Submitted: 2020-05-12
• Study First Submitted QC: 2020-05-12
• Last Update Submitted: 2020-05-12
• Study First Posted: 2020-05-13
• Last Update Posted: 2020-05-13
• Primary Completion: 2021-03-30
• Study Completion: 2021-03-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

• Patients with inflammatory growth disease, those who agreed to participate in this study

Exclusion Criteria

• Those who are unable to understand or answer the questionnaire
• Those who declined to participate in this study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Inflammatory bowel disease	Interview	Patients with inflammatory bowel disease who live in COVID-19 hyperemic area

Primary Outcome Measures

Name	Time	Method
Patient's perception of COVID-19 and medical use patterns	1day	Correlation between patient's perception of COVID-19 and medical use patterns during the pandemic period

Secondary Outcome Measures

Name	Time	Method
Exacerbation of symptoms	1day	Exacerbation of symptoms in patients with IBD during the pandemic period

Trial Locations

Locations (1)

KeimyungUniversity; 🇰🇷 Daegu, Jung-gu, Korea, Republic of